Mammal Labs LLC – Trademark Portfolio

Entity Type: 16

Mammal Labs LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include PARVENTA and MAMMAL LABS. The owner is based in SAN JOSE, CA.

1754 TECHNOLOGY DR., STE 226

SAN JOSE, CA 95110

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mammal Labs LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Mammal Labs LLC have?

Mammal Labs LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does Mammal Labs LLC file in?

Mammal Labs LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Mammal Labs LLC's most well-known trademarks?

Mammal Labs LLC's registered trademark portfolio includes well-known marks such as PARVENTA and MAMMAL LABS. These are among 2 currently registered trademarks in the portfolio.

What is Mammal Labs LLC's trademark registration success rate?

Mammal Labs LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.